Prescription patterns of antihypertensives in a community health centre in Mexico City: a drug utilization study

Fundamental & Clinical Pharmacology
Adela Alba-LeonelJuan Molina-Guarneros

Abstract

Hypertension is highly prevalent; in Mexico, the 2012 National Health and Nutrition Survey reported a prevalence of hypertension of 31.5% in the adult population. Pharmacological treatment is the commonest intervention and has been shown to reduce cardiovascular mortality and morbidity, and total mortality. Accordingly, the type and number of antihypertensives used and the outcome - in terms of blood pressure (BP) control - are important. Therefore, our purpose is to learn the pattern of antihypertensive drug prescription and explore the determinants of BP control in an urban population in Mexico. A retrospective cross-sectional drug utilization study was conducted. Medical records from a community health centre were searched to identify those corresponding to patients diagnosed with hypertension; information upon antihypertensives used and control of the disease was carefully retrieved. A logistic regression model was built to know the main determinants of BP control. A sample of 345 clinical records of interest was identified. Most patients received antihypertensives (86.4%); the leading medications used were angiotensin-converting enzyme inhibitors, 63.8%; beta-blockers (26.5%), diuretics (19.8%), angiotensin-receptor blocke...Continue Reading

References

May 10, 2002·Pharmacoepidemiology and Drug Safety·Erik Bøg-HansenLennart Råstam
Dec 20, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatm
Feb 14, 2003·The New England Journal of Medicine·Lindon M H WingUNKNOWN Second Australian National Blood Pressure Study Group
Nov 5, 2003·Journal of Hypertension·Judith A Whitworth, UNKNOWN World Health Organization, International Society of Hypertension Writing Group
Dec 6, 2003·Hypertension·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Apr 27, 2004·Journal of Hypertension·Patricia M KearneyJiang He
Jan 18, 2005·Lancet·Patricia M KearneyJiang He
Feb 7, 2007·European Journal of Clinical Pharmacology·Adnan AbaciCetin Erol
Aug 22, 2007·Salud pública de México·Lilia Cárdenas-IbarrJesús Zacarías Villarreal Pérez
Jan 29, 2008·Recent Patents on Anti-infective Drug Discovery·Weimin ZhangQi Cheng
Dec 5, 2008·The New England Journal of Medicine·Kenneth JamersonUNKNOWN ACCOMPLISH Trial Investigators
Jun 27, 2009·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Axel C CarlssonMai-Lis Hellénius
Dec 31, 2009·International Journal of Clinical Pharmacology and Therapeutics·T O OlanrewajuE O Sanya
Jul 24, 2010·Salud pública de México·Simón BarqueraCarlos A Aguilar-Salinas
Aug 4, 2012·Revista peruana de medicina experimental y salud pública·Juan M Cossio-Brazzan
Sep 20, 2012·Journal of Hypertension·Jose L LlisterriUNKNOWN PRESCAP 2010 investigators
Oct 31, 2012·Bulletin of the World Health Organization·Octavio Gómez-DantésMaki Ortiz
Aug 21, 2013·Fundamental & Clinical Pharmacology·Jacques BlacherUNKNOWN French Society of Hypertension
Dec 23, 2014·Annals of Internal Medicine·Johan SundströmUNKNOWN Blood Pressure Lowering Treatment Trialists' Collaboration

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

American Family Physician
Lori M Dickerson, Maria V Gibson
The Journal of Clinical Hypertension
Joel M Neutel, Lawrence I Gilderman
Current Hypertension Reports
Tonje Amb AksnesGiuseppe Mancia
The Canadian Journal of Cardiology
N M Robitaille
© 2022 Meta ULC. All rights reserved